kabutan

ReproCELL Incorporated(4978) Summary

4978
TSE Growth
ReproCELL Incorporated
149
JPY
0
(0.00%)
Dec 12, 3:30 pm JST
0.95
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
148
Dec 13, 1:32 am JST
Summary Chart Historical News Financial Result
PER
PBR
1.63
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
149 JPY 0.95 USD
Previous Close Dec 11
149 JPY 0.95 USD
High Dec 12, 9:26 am
153 JPY 0.98 USD
Low Dec 12, 1:16 pm
147 JPY 0.94 USD
Volume
556,800
Trading Value
0.08B JPY 0.53M USD
VWAP
149.1 JPY 0.96 USD
Minimum Trading Value
14,900 JPY 95 USD
Market Cap
0.01T JPY 0.09B USD
Number of Trades
318
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,022
1-Year High Feb 6, 2025
31,812
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 5,467,600
Nov 28, 2025 0 5,210,600
Nov 21, 2025 0 5,310,000
Nov 14, 2025 0 5,477,300
Nov 7, 2025 0 5,574,300
Company Profile
ReproCELL Incorporated is a biotech venture company specializing in iPS cell-related research reagents, collaborating with the University of Tokyo and Kyoto University. The company also offers contract manufacturing services.
Sector
Chemicals
ReproCELL Incorporated develops businesses centered on iPS cell-related technologies. In its research support division, the company manufactures and sells research products, provides research outsourcing services, and distributes cell measurement equipment. The medical division focuses on regenerative medicine research and development, contract manufacturing of iPS cell regenerative medicine products, and clinical testing services. Currently, ReproCELL is developing three regenerative medicine products: StemCaimal, iPS neural glial cells, and tumor-infiltrating lymphocyte infusion therapy. The company's strength lies in its RNA reprogramming technology, which enables the creation of highly safe iPS cells.